Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

5.6%

1 terminated/withdrawn out of 18 trials

Success Rate

93.8%

+7.2% vs industry average

Late-Stage Pipeline

50%

9 trials in Phase 3/4

Results Transparency

20%

3 of 15 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 3
9(52.9%)
Phase 2
6(35.3%)
Phase 1
2(11.8%)
17Total
Phase 3(9)
Phase 2(6)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials
NCT07562347Not Yet Recruiting

Clinical Experience and Real-world Safety and Effectiveness of Envafolimab: Patient Access Program

Role: collaborator

NCT05599919Phase 3Completed

Nitric Oxide Nasal Spray (NONS) To Treat and Prevent the Exacerbation of Infection in Individuals With Mild COVID-19

Role: collaborator

NCT05363202Phase 3Unknown

To Study Generic Fluticasone Propionate Inhalation Aerosol for the Treatment of Bronchial Asthma

Role: lead

NCT02318303Phase 2Completed

To Study GSP 301 in Patients With Seasonal Allergic Rhinitis

Role: lead

NCT03731091Phase 3Completed

To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).

Role: lead

NCT02601703Phase 3Completed

To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)

Role: lead

NCT02896101Phase 3Completed

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

Role: lead

NCT03331523Phase 3Completed

To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp Psoriasis

Role: lead

NCT03444506Phase 2Completed

Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)

Role: lead

NCT02668796Phase 3Completed

To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.

Role: lead

NCT02596451Phase 3Completed

To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).

Role: lead

NCT02465632Phase 3Completed

To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.

Role: lead

NCT02235727Phase 1Completed

Safety and Tolerability of GBR 900 in a Single Ascending Dose Study in Healthy Subjects

Role: lead

NCT02179645Phase 1Completed

GRC 27864 First in Man, Single Ascending Dose Study in Healthy Volunteers

Role: lead

NCT01726413Phase 2Completed

A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients).

Role: lead

NCT01436890Phase 2Completed

A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma

Role: lead

NCT01430507Phase 2Completed

A Clinical Trial to Study the Effects of Revamilast in Patients With Rheumatoid Arthritis

Role: lead

NCT01556152Phase 2Withdrawn

A Clinical Trial to Study the Effects of GRC 17536 in Patients With Painful Diabetic Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients)

Role: lead

All 18 trials loaded